Comparing two ways of minimally invasive esophagus surgery for cancer
Part of Cancer clinical trials.
This trial compares two types of minimally invasive surgery for esophageal cancer to see which is better. It is for people whose cancer can be removed with surgery and who are healthy enough for either approach.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You have squamous cell or adenocarcinoma of the middle or lower esophagus or the area where the esophagus meets the stomach (types Siewert 1 or 2)
- Your cancer has not spread to other organs (stage M0) and is considered curable with surgery
- You are well enough to have surgery (performance status 0, 1, or 2) and your general health is acceptable (if 70-80, a special score or doctor's okay is needed)
- You have not had major abdominal or right chest surgery in the past, and you do not have serious heart, lung, or liver problems
- You are willing and able to follow study visits and procedures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a robot-assisted approach to a standard minimally invasive approach for surgery in people with certain types of esophageal or gastroesophageal junction cancer that can be removed. It aims to see which surgery method works better and is safer for these patients.
This trial compares two surgical techniques for treating a specific type of cancer at the junction of the stomach and esophagus. It aims to find which surgery offers better outcomes for patients.
This trial compares two different surgical approaches for people with esophageal cancer who have already received treatment like chemo or radiation before surgery. It aims to see which method works better and is safer.
This study compares two minimally invasive ways to operate on the stomach area for cancers near the stomach and esophagus (GEJ). It looks at whether one surgical approach is better for long-term outcomes when the goal is cure.
This study compares two surgical approaches (right side of the chest vs. left side of the chest) for removing a certain type of cancer at the gastroesophageal junction. It aims to find which approach leads to better outcomes.
This trial compares two types of stomach-removing surgeries (total vs. partial gastrectomy) in people with a certain kind of advanced gastroesophageal junction cancer. The goal is to find out which surgery leads to better outcomes.
Hear when a new Resecable Esophageal or Gastroesophageal Junction Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.